Nitric oxide in the flocculus works the inhibitory neural circuits after unilateral labyrinthectomy.
We previously reported that nitric oxide (NO) production in the unipolar brush (UB) cells is involved in vestibular compensation [T. Kitahara, N. Takeda, P.C. Emson, T. Kubo, H. Kiyama, Changes in nitric oxide synthase-like immunoreactivities in unipolar brush cells in the rat cerebellar flocculus after unilateral labyrinthectomy, Brain Res. 765 (1997) 1-6]. To further elucidate the role of NO-mediated signaling in flocculus after unilateral labyrinthectomy (UL), we examined UL-induced Fos expression, a marker of neural activity, in vestibular brainstem with continuous floccular infusions of Nomega-nitro-l-arginine methyl ester (l-NAME), an inhibitor of NO synthase (NOS). After UL with floccular l-NAME infusions, Fos expression appeared in bilateral medial vestibular (MVe) and prepositus hypoglossal (PrH) nuclei. After UL with floccular saline infusions, however, Fos expression was observed only in the ipsi-MVe and contra-PrH. Furthermore, it has been revealed that UL with l-NAME infusions caused more severe vestibulo-ocular disturbances than UL with saline infusions at the initial stage [Kitahara et al. Brain Res. 765 (1997) 1-6]. Therefore, it is suggested that UL with floccular l-NAME infusions activates the contra-MVe and ipsi-PrH neurons and causes more severe imbalance between intervestibular nuclear activities at the initial stage. NO-mediated signaling in flocculus could be a possible driving force of the flocculus-mediated inhibition on the contra-MVe and ipsi-PrH at the initial stage of vestibular compensation.
Kitahara
T
T
Department of Otolaryngology, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. kitahara@ent.med.osaka-u.ac.jp
Takeda
N
N
Kubo
T
T
Kiyama
H
H
D000818:Animals; D001931:Brain Mapping; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D007758:Ear, Inner / Q000502:physiology*; D007839:Functional Laterality; D007263:Infusions, Parenteral; D019331:NG-Nitroarginine Methyl Ester / Q000008:administration & dosage; D009434:Neural Pathways / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D014726:Vestibular Nuclei / Q000187:drug effects / Q000502:physiology
D009569:Nitric Oxide; D019331:NG-Nitroarginine Methyl Ester